The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,114.00
Bid: 12,114.00
Ask: 12,116.00
Change: 90.00 (0.75%)
Spread: 2.00 (0.017%)
Open: 11,950.00
High: 12,142.00
Low: 11,944.00
Prev. Close: 12,024.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks slip as investors digest earnings, Barclays rises

Wed, 30th Jul 2014 08:26

- Barclays rises as investors digest wave of corporate earnings- Russian sanctions, Gaza and Argentina in focus- US economic data, Fed decision due out later ontechMARK 2,785.48 +0.12%FTSE 100 6,797.66 -0.15%FTSE 250 15,671.08 -0.10%UK markets opened slightly lower on Wednesday as investors digested a wave of corporate earnings and cautiously awaited economic data and a policy decision Stateside later on.Meanwhile, traders were still watching developments in the Ukraine crisis after US and EU leaders announced a fresh round of sanctions on Russia yesterday. Relentless fighting in Gaza and a potential debt default in Argentina were also likely to be weighing on risk appetite.The FTSE 100 was trading down 0.2% at 6,798 in early trading as strong gains from Barclays, Travis Perkins and AstraZeneca were offset by falls from Antofagasta, ITV and Tullow Oil.After a relatively quiet start to the week macro-wise, things will pick up today with a flurry of economic indicators due out during the morning session, including Eurozone confidence data and Germany inflation.However, the focus is likely to be on the US later on with the closely-watched ADP employment report and second-quarter gross domestic product (GDP) estimates due out before the opening bell on Wall Street, and the Federal Reserve's policy decision scheduled for this evening.Angus Campbell, Senior Analyst at FxPro, said that the GDP figures are "like to move the market most - this is because tonight's [Fed meeting] does not include a press conference and so there's unlikely to be any changes to what we saw or heard last month".Barclays leads banks higherBarclays was a high riser this morning as it reported a less-than-expected 12% fall in total income adjusted for insurance claims for the first half to £13.32bn, driven by reductions at its investment and African banking units. The consensus estimate had been for a drop to £13.23bn.Domestic banking peers RBS and Lloyds were also on the rise.Housebuilder Travis Perkins also impressed as it reported double-digit growth across the board in the first half, with like-for-like revenues up 10.2% and profits up 16%. The company said it expects "continued solid growth" for the rest of the year.Astrazeneca was in demand after it struck a deal with drug developer Almirall for the rights to the Spanish group's respiratory franchise. The initial consideration is $875m,Chile-focused mining group Antofagasta underwhelmed as it maintained its production guidance for 2014 after a sequential increase in output in the second quarter, while net cash costs were broadly flat.Shares of broadcaster ITV were in negative territory with the stock retreating after its recent strong run. Nevertheless, the company managed to beat expectations with its first-half results this morning with pre-tax profits up 16%.Also lower was Tullow Oil as it dropped into the red in the first half of 2014, after exploration write-offs more than doubled. Tullow reported a loss before tax of $29m in the first six months of the year, compared with a profit of $486m in the first half of 2013.FTSE 100 - RisersBarclays (BARC) 226.35p +3.31%Travis Perkins (TPK) 1,679.00p +2.07%Severn Trent (SVT) 1,955.00p +0.93%AstraZeneca (AZN) 4,353.00p +0.71%Royal Bank of Scotland Group (RBS) 356.20p +0.62%Capita (CPI) 1,222.00p +0.58%Carnival (CCL) 2,139.00p +0.56%BT Group (BT.A) 389.00p +0.52%Reckitt Benckiser Group (RB.) 5,245.00p +0.48%Vodafone Group (VOD) 203.70p +0.39%FTSE 100 - FallersAntofagasta (ANTO) 838.00p -1.99%Sainsbury (J) (SBRY) 318.40p -1.52%GKN (GKN) 360.60p -1.48%CRH (CRH) 1,442.00p -1.44%Compass Group (CPG) 994.00p -1.39%WPP (WPP) 1,196.00p -0.99%Rio Tinto (RIO) 3,441.00p -0.98%TUI Travel (TT.) 364.50p -0.84%Morrison (Wm) Supermarkets (MRW) 173.10p -0.80%Sports Direct International (SPD) 687.50p -0.79%FTSE 250 - RisersPets at Home Group (PETS) 182.30p +7.24%Riverstone Energy Limited (RSE) 925.00p +2.21%IP Group (IPO) 195.90p +2.14%Dignity (DTY) 1,408.00p +1.88%Perform Group (PER) 211.00p +1.78%National Express Group (NEX) 261.00p +1.68%Diploma (DPLM) 635.50p +1.68%Fisher (James) & Sons (FSJ) 1,337.00p +1.60%Taylor Wimpey (TW.) 116.40p +1.57%BTG (BTG) 616.00p +1.48%FTSE 250 - FallersVedanta Resources (VED) 1,057.00p -3.03%Jupiter Fund Management (JUP) 406.70p -2.02%Investec (INVP) 525.50p -1.78%Pace (PIC) 355.90p -1.66%Betfair Group (BET) 1,026.00p -1.63%Beazley (BEZ) 254.30p -1.59%Rotork (ROR) 2,767.00p -1.53%Spectris (SXS) 1,931.00p -1.48%International Personal Finance (IPF) 577.50p -1.45%Fenner (FENR) 337.60p -1.43%BC
More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.